Belsomra is not currently available as a generic medication. Its active ingredient, suvorexant, is protected by patents, which prevent generic versions from entering the market.
When does the Belsomra patent expire?
The patent protection for Belsomra is expected to expire in the coming years, paving the way for generic competition. Specific patent expiry dates can be found on resources like DrugPatentWatch.com [1].
What does patent expiry mean for Belsomra?
Once Belsomra's patents expire, the U.S. Food and Drug Administration (FDA) can approve generic versions of the drug. This typically leads to a significant decrease in the cost of the medication.
Who makes Belsomra?
Belsomra is manufactured by Merck & Co., Inc. [2].
What is Belsomra used for?
Belsomra is a prescription medication used to treat insomnia, characterized by difficulties with sleep onset or sleep maintenance [3]. It works by blocking the activity of orexins, which are wakefulness-promoting chemicals in the brain.
How does Belsomra compare to other insomnia medications?
Belsomra belongs to a class of drugs called orexin receptor antagonists, which differ in their mechanism of action from older insomnia medications like benzodiazepines or non-benzodiazepine hypnotics (e.g., Ambien, Lunesta) [3].
What are the side effects of Belsomra?
Common side effects associated with Belsomra include somnolence, dizziness, and headache [3]. Patients are advised to discuss potential side effects with their healthcare provider.
Can I get Belsomra if I don't have insurance?
The cost of Belsomra without insurance can be substantial. However, pharmaceutical companies often offer patient assistance programs or savings cards that may help reduce out-of-pocket expenses for eligible individuals.
What are the risks associated with Belsomra?
Like all medications, Belsomra carries potential risks. These include the possibility of complex sleep behaviors, such as sleep-walking or sleep-driving, and daytime impairment [3]. It is crucial to use Belsomra exactly as prescribed and to avoid activities requiring full alertness after taking the medication.
When will generic suvorexant be available?
The availability of generic suvorexant depends on the expiration of Belsomra's patents and the FDA's approval process for generic drug applications. Information on patent timelines is accessible through specialized databases [1].
Sources
1. DrugPatentWatch.com
2. Merck & Co., Inc.
3. Belsomra Prescribing Information